Heart failure and transplantation with Dr Ileana Piña

AHA 2024 REALIZE-K: A New Potassium Binder to Help Keep Spiro on Board Heart failure expert Ileana Piña discusses potassium-binder use in patients with hyperkalemia while taking spironolactone, including results for zirconium cyclosilicate from the REALIZE-K trial.
Commentary, December 03, 2024
AHA 2024 Heart Failure GDMT: Could Pharmacists Be the Fifth Pillar? Drs Ileana Piña and Alexander Sandhu discuss the PHARM-HF trial, which tested three strategies to help pharmacists get patients with heart failure on the right drugs at the right doses.
Commentary, November 26, 2024
ESC 2024 Can You Deprescribe After Ejection Fraction Improvement? Drs Ileana Piña and Deborah Belfort discuss the CATHEDRAL-HF trial in patients with improved ejection fraction which had some stay on the beta-blocker carvedilol but discontinue other HF meds.
Commentary, October 07, 2024
ESC 2024 The AF is Gone, the EF Is Up. Can You Stop the HF Meds? Ileana Piña interviews study investigators Louise Segan and Sandeep Prabhu about WITHDRAW-AF, which tested careful cessation of most HF meds in patients with recovered EF and AF regression.
Commentary, September 25, 2024
ESC 2024 The FINEART of MRAs in HFpEF Ileana Piña, MD, gets the details on the FINEARTS-HF trial of finerenone in patients with heart failure with preserved ejection fraction from the principal investigator Scott Solomon, MD.
Commentary, September 10, 2024
ACC 2024 Patient-Reported Outcomes in Heart Failure: How Do You Feel? Drs Ileana Piña and Alexander Sandhu discuss the PRO-HF trial and potential discrepancies between physician and patient perceptions of how the patient is doing.
Commentary, May 01, 2024
ACC 2024 Semaglutide Benefits in HFpEF Step Beyond Weight Loss Drs Piña and Kosiborod discuss semaglutide in obesity-related HF with and without diabetes. Both STEP HFpEF trials show similar HF benefits despite less weight loss in patients with diabetes.
Commentary, April 12, 2024
Is the Price Right? Heart Failure Drug Choices The best drug therapy in heart failure may be dictated by what the patient can afford. Ileana Piña interviews Neal Dickert about his study on integrating drug prices into patient discussions.
Experts And Viewpoints, January 22, 2024
Predicting HF Worsening: Speech Analysis Beats Weighing Scales Heart failure experts, Ileana Piña and Bill Abraham, discuss the HearO study on the use of AI for detecting congestion remotely and other tips and tricks they have learned over the years.
Experts And Viewpoints, December 04, 2023
Quick, Reliable Marker to PUSH Decongestive Therapy in AHF Ileana Piña and Wilfried Mullens discuss the PUSH-AHF trial on a spot urine sodium protocolized approach to decongestion presented at the European Society of Cardiology.
Experts And Viewpoints, October 16, 2023
SGLT2i in Acute Heart Failure, The Earlier The Better? Ileana Piña interviews Zachary Cox, PharmD, about the DICTATE-AHF trial on the initiation of the SGLT2 inhibitor, dapagliflozin, early in acute heart failure decompensation.
Experts And Viewpoints, September 20, 2023
Heart Failure Guidelines Update: What the ESC Got Right Heart failure specialist Dr Ileana Piña discusses what she likes about the 2023 ESC focused update to the heart failure guidelines.
Experts And Viewpoints, September 08, 2023
GLP-1 Agonists in HFpEF With Obesity: Are We There Yet? Obesity, a driver of inflammation, is prevalent in patients with HFpEF. Ileana Pina asks Ambarish Pandey about GLP-1 agonists and SGLT2 inhibitors in HFpEF. Are these drugs anti-inflammatory?
Experts And Viewpoints, July 27, 2023
ACC HFpEF Guidance: What to Know Ileana Piña, MD, MPH, discusses the Expert Consensus Decision Pathway from ACC focused on the definition, diagnosis, and treatment of heart failure with preserved ejection fraction.
Experts And Viewpoints, May 18, 2023
Defining Heart Failure: EF Slicing and Dicing Ileana L. Piña, MD, MPH, discusses the definition of heart failure based on various ejection fraction ranges and changes.
Experts And Viewpoints, May 05, 2023
Clues to How SGLT2 Inhibitors Work: CAMEO-DAPA Ileana Piña, MD, MPH, and Barry A. Borlaug, MD, discuss the CAMEO-DAPA study in patients with HFpEF and potential mechanisms of action for SGLT2 inhibitors.
Experts And Viewpoints, April 20, 2023
STRONG-HF: This Is the Science, Let's Get It Done Ileana L. Piña, MD, MPH, discusses the need to implement the findings of STRONG-HF in heart failure clinics across the globe.
Experts And Viewpoints, April 03, 2023
A 'Game Changer' for Heart Transplant? Dr DeVore, from the first US center to perform an adult heart transplant using an organ donated after circulatory death, explains the differences and similarities with brain-dead donation to Dr Piña.
Experts And Viewpoints, March 24, 2023
AHA 2022 Is Finding and Fixing Iron Deficiency in HF Beneficial? Ileana Piña interviews Paul Kalra about the IRONMAN trial from the American Heart Association which randomized HF patients with iron deficiency to IV ferric derisomaltose repletion or no infusions.
Experts And Viewpoints, November 30, 2022
AHA 2022 STRONG-HF Strategy for Intense ADHF Discharge Care Explained Alexandre Mebazaa gives Ileana Piña the details on the STRONG-HF trial that showed benefits for early intensive drug therapy after hospitalization for acute decompensated heart failure.
Experts And Viewpoints, November 14, 2022

No Results